You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pam2CSK4 acetate and ODN M362 combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)

Not yet recruiting
  • Biliary Tract Cancer
  • Clayton, Australia
  • +65 more
Oct 26, 2023

COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

Completed
  • COVID-19
  • PUL-042 Inhalation Solution
  • Placebo
  • Orange, California
  • +14 more
Sep 1, 2021

Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • San Diego, California
  • +25 more
Jan 10, 2023

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

Completed
  • COVID-19
  • PUL-042 Inhalation Solution
  • Placebo
  • Orange, California
  • +10 more
Jul 14, 2021

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (zolbetuximab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Goodyear, Arizona
  • +131 more
Jan 30, 2023

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (biological, drug, other)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Pembrolizumab 200 mg
  • +11 more
  • Los Angeles, California
  • +30 more
Aug 12, 2022

COPD Trial in London (Sterile Water Injection, PUL-042 Inhalation Solution)

Completed
  • COPD
  • Sterile Water Injection
  • PUL-042 Inhalation Solution
  • London, United Kingdom
    Imperial College Healthcare NHS Trust, St Mary Hospital
May 28, 2021

Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

Recruiting
  • Metastatic Castrate Sensitive Prostate Cancer
  • Homewood, Alabama
  • +439 more
Jan 17, 2023

NSCLC (NSCLC) Trial in Worldwide (Tiragolumab, Atezolizumab, Pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Jonesboro, Arkansas
  • +138 more
Jan 17, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate/Niraparib
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 9, 2023

Advanced Castrate-resistant Prostate Cancer CRPC, Squamous NSCLC sqNSCLC, Triple Negative Breast Cancer TNBC Trial in Worldwide

Completed
  • Advanced Castrate-resistant Prostate Cancer CRPC
  • +2 more
  • Part A: AZD8186 monotherapy
  • +5 more
  • Boston, Massachusetts
  • +12 more
May 28, 2020

Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Docetaxel / Capecitabine
  • +5 more
  • Cairo, Egypt
  • +51 more
Oct 24, 2022

Colo-rectal Cancer Trial in Worldwide (Arfolitixorin, Leucovorin)

Active, not recruiting
  • Colo-rectal Cancer
  • Gilbert, Arizona
  • +93 more
Mar 29, 2022

Colorectal Tumors Trial in Worldwide (Nivolumab-relatlimab FDC, Regorafenib, TAS-102)

Recruiting
  • Colorectal Neoplasms
  • Nivolumab-relatlimab FDC
  • +2 more
  • Rogers, Arkansas
  • +118 more
Aug 16, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-Sensitive Prostate Cancer
  • Tucson, Arizona
  • +192 more
Nov 6, 2023

Triple-Negative Breast Cancer Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody, Atezolizumab

Active, not recruiting
Has Results
  • Triple-Negative Breast Cancer
  • Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody
  • +2 more
  • Stanford, California
  • +160 more
Oct 26, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Innate on the Inflammatory Response to Endotoxin

Recruiting
  • Asthma
  • +4 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Dec 7, 2022

    Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

    Not yet recruiting
    • Liver Metastasis Colon Cancer
    • IRE plus checkpoint inhibitor
    • IRE plus Checkpoint Inhibitor plus CpG-ODN
    • (no location specified)
    Sep 13, 2023

    Esophageal Squamous Cell Carcinoma Trial in Worldwide (Durvalumab, Placebo, cisplatin + fluorouracil)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Tucson, Arizona
    • +165 more
    Jan 18, 2023